Medtronic Declares Q2 FY2027 Dividend of $0.72 Per Share

Medtronic plc (NYSE: MDT) announced that its board of directors approved a cash dividend of $0.72 per ordinary share for the second quarter of fiscal year 2027. The dividend is payable on October 16, 2026, to shareholders of record at the close of business on September 25, 2026.

Dividend Consistency and Aristocrat Status

This quarterly declaration aligns with the dividend increase the company announced in June 2026. Medtronic is a member of the S&P 500 Dividend Aristocrats index, reflecting its track record of increasing its annual dividend payment for 49 consecutive years. The company's long-standing commitment to returning capital to shareholders is a key aspect of its financial profile.

Company Overview

Headquartered in Galway, Ireland, Medtronic is a global healthcare technology company. Its mission is to alleviate pain, restore health, and extend life. The company employs over 95,000 people across more than 150 countries and offers technologies and therapies that address 70 health conditions, including cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems.

Medtronic's innovations are designed to transform the lives of two people every second, every hour, every day. The company focuses on delivering insight-driven care and better outcomes for patients worldwide.

What it means for income investors

Medtronic's consistent dividend payments and its inclusion in the Dividend Aristocrats index highlight its stability as a dividend payer. The declared dividend of $0.72 per share continues the company's pattern of regular quarterly distributions, which may appeal to income-focused investors seeking reliable cash flow.

Reporting based on: Medtronic. Figures verified against market data where available.